1. Home
  2. XBIT vs CPHC Comparison

XBIT vs CPHC Comparison

Compare XBIT & CPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.54

Market Cap

75.0M

Sector

Health Care

ML Signal

HOLD

Logo Canterbury Park Holding Corporation 'New'

CPHC

Canterbury Park Holding Corporation 'New'

HOLD

Current Price

$15.55

Market Cap

79.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIT
CPHC
Founded
2005
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
75.0M
79.9M
IPO Year
2015
2016

Fundamental Metrics

Financial Performance
Metric
XBIT
CPHC
Price
$2.54
$15.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.9K
1.2K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
1.79%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$59,227,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.14
52 Week Low
$2.09
$14.49
52 Week High
$3.61
$21.61

Technical Indicators

Market Signals
Indicator
XBIT
CPHC
Relative Strength Index (RSI) 63.66 52.30
Support Level $2.17 $15.24
Resistance Level $2.69 $15.78
Average True Range (ATR) 0.10 0.12
MACD 0.01 0.00
Stochastic Oscillator 72.97 61.97

Price Performance

Historical Comparison
XBIT
CPHC

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About CPHC Canterbury Park Holding Corporation 'New'

Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the real estate development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.

Share on Social Networks: